Use of 12-dehydroabietic acid oxime ether derivative
The invention relates to a use of a 12-dehydroabietic acid oxime ether derivative. The 12-dehydroabietic acid oxime ether derivative has good inhibition activity on Staphylococcus aureus newman strains, and also has certain inhibition activity on some drug-resistant strains, such as NRS-1 strains (...
Gespeichert in:
| Hauptverfasser: | , , , , , |
|---|---|
| Format: | Patent |
| Sprache: | chi ; eng |
| Schlagworte: | |
| Online-Zugang: | Volltext bestellen |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
| container_end_page | |
|---|---|
| container_issue | |
| container_start_page | |
| container_title | |
| container_volume | |
| creator | WANG TIANQI YANG CAIGUANG LIN HAIXIA PAN XUEYING ZHANG WENMING CUI YONGMEI |
| description | The invention relates to a use of a 12-dehydroabietic acid oxime ether derivative. The 12-dehydroabietic acid oxime ether derivative has good inhibition activity on Staphylococcus aureus newman strains, and also has certain inhibition activity on some drug-resistant strains, such as NRS-1 strains ( aminoglycoside antibiotic and tetracycline resistant Staphylococcus aureus), NRS-70 strains (erythromycin and spectinomycin resistant Staphylococcus aureus), NRS-100 strains (oxacillin and tetracycline resistant Staphylococcus aureus), NRS-108 strains (gentamycin resistant Staphylococcus aureus) and NRS-271 strains (methicillin and linezolid resistant Staphylococcus aureus).
本发明涉及种12-肟醚脱氢枞酸衍生物的用途。12-肟醚脱氢枞酸衍生物对金黄色葡萄球菌newman菌株有较好的抑制活性，同时对些耐药菌株如NRS-1菌株(耐氨基糖苷类抗生素和四环素的金黄色葡萄球菌)、NRS-70菌株(耐红霉素和奇放线菌素的金黄色葡萄球菌)、NRS-100 菌株(耐苯唑青霉素和四环素的金黄色葡萄球菌)、NRS-108 菌株(耐庆大霉素的金黄色葡萄球菌)、NRS-271 菌株(耐甲氧西林和利奈唑胺的金黄色葡萄球菌)均有定程度的抑制活性。 |
| format | Patent |
| fullrecord | <record><control><sourceid>epo_EVB</sourceid><recordid>TN_cdi_epo_espacenet_CN105935355A</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>CN105935355A</sourcerecordid><originalsourceid>FETCH-epo_espacenet_CN105935355A3</originalsourceid><addsrcrecordid>eNrjZDAJLU5VyE9TMDTSTUnNqEwpyk9MykwtyUxWSEzOTFHIr8jMTVVILclILVJISS3KLEssySxL5WFgTUvMKU7lhdLcDIpuriHOHrqpBfnxqcUFicmpeakl8c5-hgamlsamxqamjsbEqAEA2QUsMw</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>patent</recordtype></control><display><type>patent</type><title>Use of 12-dehydroabietic acid oxime ether derivative</title><source>esp@cenet</source><creator>WANG TIANQI ; YANG CAIGUANG ; LIN HAIXIA ; PAN XUEYING ; ZHANG WENMING ; CUI YONGMEI</creator><creatorcontrib>WANG TIANQI ; YANG CAIGUANG ; LIN HAIXIA ; PAN XUEYING ; ZHANG WENMING ; CUI YONGMEI</creatorcontrib><description>The invention relates to a use of a 12-dehydroabietic acid oxime ether derivative. The 12-dehydroabietic acid oxime ether derivative has good inhibition activity on Staphylococcus aureus newman strains, and also has certain inhibition activity on some drug-resistant strains, such as NRS-1 strains ( aminoglycoside antibiotic and tetracycline resistant Staphylococcus aureus), NRS-70 strains (erythromycin and spectinomycin resistant Staphylococcus aureus), NRS-100 strains (oxacillin and tetracycline resistant Staphylococcus aureus), NRS-108 strains (gentamycin resistant Staphylococcus aureus) and NRS-271 strains (methicillin and linezolid resistant Staphylococcus aureus).
本发明涉及种12-肟醚脱氢枞酸衍生物的用途。12-肟醚脱氢枞酸衍生物对金黄色葡萄球菌newman菌株有较好的抑制活性，同时对些耐药菌株如NRS-1菌株(耐氨基糖苷类抗生素和四环素的金黄色葡萄球菌)、NRS-70菌株(耐红霉素和奇放线菌素的金黄色葡萄球菌)、NRS-100 菌株(耐苯唑青霉素和四环素的金黄色葡萄球菌)、NRS-108 菌株(耐庆大霉素的金黄色葡萄球菌)、NRS-271 菌株(耐甲氧西林和利奈唑胺的金黄色葡萄球菌)均有定程度的抑制活性。</description><language>chi ; eng</language><subject>ACYCLIC OR CARBOCYCLIC COMPOUNDS ; CHEMISTRY ; HUMAN NECESSITIES ; HYGIENE ; MEDICAL OR VETERINARY SCIENCE ; METALLURGY ; ORGANIC CHEMISTRY ; PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES ; SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS</subject><creationdate>2016</creationdate><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20160914&DB=EPODOC&CC=CN&NR=105935355A$$EHTML$$P50$$Gepo$$Hfree_for_read</linktohtml><link.rule.ids>230,308,780,885,25563,76318</link.rule.ids><linktorsrc>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20160914&DB=EPODOC&CC=CN&NR=105935355A$$EView_record_in_European_Patent_Office$$FView_record_in_$$GEuropean_Patent_Office$$Hfree_for_read</linktorsrc></links><search><creatorcontrib>WANG TIANQI</creatorcontrib><creatorcontrib>YANG CAIGUANG</creatorcontrib><creatorcontrib>LIN HAIXIA</creatorcontrib><creatorcontrib>PAN XUEYING</creatorcontrib><creatorcontrib>ZHANG WENMING</creatorcontrib><creatorcontrib>CUI YONGMEI</creatorcontrib><title>Use of 12-dehydroabietic acid oxime ether derivative</title><description>The invention relates to a use of a 12-dehydroabietic acid oxime ether derivative. The 12-dehydroabietic acid oxime ether derivative has good inhibition activity on Staphylococcus aureus newman strains, and also has certain inhibition activity on some drug-resistant strains, such as NRS-1 strains ( aminoglycoside antibiotic and tetracycline resistant Staphylococcus aureus), NRS-70 strains (erythromycin and spectinomycin resistant Staphylococcus aureus), NRS-100 strains (oxacillin and tetracycline resistant Staphylococcus aureus), NRS-108 strains (gentamycin resistant Staphylococcus aureus) and NRS-271 strains (methicillin and linezolid resistant Staphylococcus aureus).
本发明涉及种12-肟醚脱氢枞酸衍生物的用途。12-肟醚脱氢枞酸衍生物对金黄色葡萄球菌newman菌株有较好的抑制活性，同时对些耐药菌株如NRS-1菌株(耐氨基糖苷类抗生素和四环素的金黄色葡萄球菌)、NRS-70菌株(耐红霉素和奇放线菌素的金黄色葡萄球菌)、NRS-100 菌株(耐苯唑青霉素和四环素的金黄色葡萄球菌)、NRS-108 菌株(耐庆大霉素的金黄色葡萄球菌)、NRS-271 菌株(耐甲氧西林和利奈唑胺的金黄色葡萄球菌)均有定程度的抑制活性。</description><subject>ACYCLIC OR CARBOCYCLIC COMPOUNDS</subject><subject>CHEMISTRY</subject><subject>HUMAN NECESSITIES</subject><subject>HYGIENE</subject><subject>MEDICAL OR VETERINARY SCIENCE</subject><subject>METALLURGY</subject><subject>ORGANIC CHEMISTRY</subject><subject>PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES</subject><subject>SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS</subject><fulltext>true</fulltext><rsrctype>patent</rsrctype><creationdate>2016</creationdate><recordtype>patent</recordtype><sourceid>EVB</sourceid><recordid>eNrjZDAJLU5VyE9TMDTSTUnNqEwpyk9MykwtyUxWSEzOTFHIr8jMTVVILclILVJISS3KLEssySxL5WFgTUvMKU7lhdLcDIpuriHOHrqpBfnxqcUFicmpeakl8c5-hgamlsamxqamjsbEqAEA2QUsMw</recordid><startdate>20160914</startdate><enddate>20160914</enddate><creator>WANG TIANQI</creator><creator>YANG CAIGUANG</creator><creator>LIN HAIXIA</creator><creator>PAN XUEYING</creator><creator>ZHANG WENMING</creator><creator>CUI YONGMEI</creator><scope>EVB</scope></search><sort><creationdate>20160914</creationdate><title>Use of 12-dehydroabietic acid oxime ether derivative</title><author>WANG TIANQI ; YANG CAIGUANG ; LIN HAIXIA ; PAN XUEYING ; ZHANG WENMING ; CUI YONGMEI</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-epo_espacenet_CN105935355A3</frbrgroupid><rsrctype>patents</rsrctype><prefilter>patents</prefilter><language>chi ; eng</language><creationdate>2016</creationdate><topic>ACYCLIC OR CARBOCYCLIC COMPOUNDS</topic><topic>CHEMISTRY</topic><topic>HUMAN NECESSITIES</topic><topic>HYGIENE</topic><topic>MEDICAL OR VETERINARY SCIENCE</topic><topic>METALLURGY</topic><topic>ORGANIC CHEMISTRY</topic><topic>PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES</topic><topic>SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS</topic><toplevel>online_resources</toplevel><creatorcontrib>WANG TIANQI</creatorcontrib><creatorcontrib>YANG CAIGUANG</creatorcontrib><creatorcontrib>LIN HAIXIA</creatorcontrib><creatorcontrib>PAN XUEYING</creatorcontrib><creatorcontrib>ZHANG WENMING</creatorcontrib><creatorcontrib>CUI YONGMEI</creatorcontrib><collection>esp@cenet</collection></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext_linktorsrc</fulltext></delivery><addata><au>WANG TIANQI</au><au>YANG CAIGUANG</au><au>LIN HAIXIA</au><au>PAN XUEYING</au><au>ZHANG WENMING</au><au>CUI YONGMEI</au><format>patent</format><genre>patent</genre><ristype>GEN</ristype><title>Use of 12-dehydroabietic acid oxime ether derivative</title><date>2016-09-14</date><risdate>2016</risdate><abstract>The invention relates to a use of a 12-dehydroabietic acid oxime ether derivative. The 12-dehydroabietic acid oxime ether derivative has good inhibition activity on Staphylococcus aureus newman strains, and also has certain inhibition activity on some drug-resistant strains, such as NRS-1 strains ( aminoglycoside antibiotic and tetracycline resistant Staphylococcus aureus), NRS-70 strains (erythromycin and spectinomycin resistant Staphylococcus aureus), NRS-100 strains (oxacillin and tetracycline resistant Staphylococcus aureus), NRS-108 strains (gentamycin resistant Staphylococcus aureus) and NRS-271 strains (methicillin and linezolid resistant Staphylococcus aureus).
本发明涉及种12-肟醚脱氢枞酸衍生物的用途。12-肟醚脱氢枞酸衍生物对金黄色葡萄球菌newman菌株有较好的抑制活性，同时对些耐药菌株如NRS-1菌株(耐氨基糖苷类抗生素和四环素的金黄色葡萄球菌)、NRS-70菌株(耐红霉素和奇放线菌素的金黄色葡萄球菌)、NRS-100 菌株(耐苯唑青霉素和四环素的金黄色葡萄球菌)、NRS-108 菌株(耐庆大霉素的金黄色葡萄球菌)、NRS-271 菌株(耐甲氧西林和利奈唑胺的金黄色葡萄球菌)均有定程度的抑制活性。</abstract><oa>free_for_read</oa></addata></record> |
| fulltext | fulltext_linktorsrc |
| identifier | |
| ispartof | |
| issn | |
| language | chi ; eng |
| recordid | cdi_epo_espacenet_CN105935355A |
| source | esp@cenet |
| subjects | ACYCLIC OR CARBOCYCLIC COMPOUNDS CHEMISTRY HUMAN NECESSITIES HYGIENE MEDICAL OR VETERINARY SCIENCE METALLURGY ORGANIC CHEMISTRY PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS |
| title | Use of 12-dehydroabietic acid oxime ether derivative |
| url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-12T02%3A38%3A57IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-epo_EVB&rft_val_fmt=info:ofi/fmt:kev:mtx:patent&rft.genre=patent&rft.au=WANG%20TIANQI&rft.date=2016-09-14&rft_id=info:doi/&rft_dat=%3Cepo_EVB%3ECN105935355A%3C/epo_EVB%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_id=info:pmid/&rfr_iscdi=true |